Company: XAIR
Filing Date: 2025-09-30
Form Type: S-3/A
Source: 0001493152-25-016266
Chunk: 2

Company: Beyond Air, Inc.
Filing Date: 2025-09-30
Form: S-3/A
Chunk 2
---
. 333-290520) solely to amend Item 16 of Part II to file the opinion of Sichenzia Ross Ference Carmel as Exhibit 5.1 and the accompanying consent as Exhibit 23.3. This Amendment does not modify any other provision of the Registration Statement contained in Part I, or Part II.

Item 16. Exhibits.

| 1.1   
 2.1   |     | At-The-Market Equity Offering Sales Agreement, dated as of February 14, 2025, filed as Exhibit 1.1 to our Current Report on Form 8-K, filed with the SEC on February 14, 2025 and incorporated herein by reference.                                                                                                             
 Agreement and Plan of Merger and Reorganization, dated as of December 29, 2016, by and among AIT Therapeutics, Inc. and Advanced Inhalation Therapies Ltd., filed as Exhibit 2.1 to our Current Report on Form 8-K, as amended and filed with the SEC on March 15, 2017 and incorporated herein by reference.                   |
|:------|:----|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.2   |     | First Amendment to Agreement and Plan of Merger and Reorganization, dated as of January 12, 2017, by and among AIT Therapeutics, Inc. and Advanced Inhalation Therapies Ltd., filed as Exhibit 2.2 to our Current Report on Form 8-K, as amended and filed with the SEC on March 15, 2017 and incorporated herein by reference. |
| 2.3   |     | Merger Completion Certificate, dated as of December 29, 2016, by and among Red Maple Ltd. And Advance Inhalation (AIT) Ltd., filed as Exhibit 2.3 to our Current Report on Form 8-K, as amended and filed with the SEC on March 15, 2017 and incorporated herein by reference.                                                  |
| 3.1   |     | Amended and Restated Certificate of Incorporation of AIT Therapeutics, Inc., dated as of January 9, 2017, filed as Exhibit 3.1 to our Current Report on Form 8-K, as amended and filed with the SEC on March 15, 2017 and incorporated herein by reference.                                                                     |
| 3.2   |     | Amended and Restated Bylaws of AIT Therapeutics,